Oleg Yerov

Oleg Yerov has a diverse work experience in the field of scientific research and development. Oleg started their career at Stryker as a Sterility Assurance-Microbiology Intern, where they gained experience in Novel Exhaustive Bioburden Testing and protocol revisions. Oleg then joined 480 Biomedical, Inc. as a Histology Research Associate, where they were involved in the Stanza® Bioresorbable Scaffold Project and performed various histological procedures on dissected sheep tissues.

In 2013, Oleg became a Research Associate at the Schepens Eye Research Institute, where they conducted a funded research project on the effect of small molecules on GDNF expression in Mouse Retina. Oleg successfully performed RT-PCR, qPCR, gel electrophoresis, and western blot procedures, as well as dissected mouse eyes to extract the retina.

Oleg's next role was as a Research Associate II at T2 Biosystems, where they developed a Novel Hemostasis Assay in whole blood on an innovative instrument. Oleg also served as the Supervisor of the Instrument Lab, responsible for scheduling and executing studies to submit a Novel Infectious Bacteria detection method to the FDA.

In 2018, Oleg joined SmartPharm Therapeutics, Inc. as an Associate Scientist, focusing on Lipid Nanoparticle encapsulated mRNA and DNA Gene Therapy for Enzyme Replacement Therapy. Oleg performed cell and plate-based methods to prove efficacy using various techniques such as ELISA, Enzymatic Activity Assays, Flow Cytometry, Western Blot, RT-PCR, and encapsulation assays. Oleg also conducted cell culture and maintenance of primary cells, immortalized cell lines, and differentiating cell lines.

Currently, Oleg works as an Associate Scientist at Xilio Therapeutics, Inc., where they started as a Senior Research Associate and was recently promoted. Their responsibilities in this role are not specified in the provided information.

From 2008 to 2013, Oleg Yerov attended Northeastern University, where they pursued a Bachelor of Science (BS) degree in Biology/Biological Sciences, General.